Skip to main content

Table 1 Comparison of clinical characteristics of Kawasaki disease according to sonographic findings of gallbladder

From: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children

Variables

Non AAC group

AAC group†

Pvalue

(n = 43)

(n = 24)

Mean age (years)

3.0 (0.2 ~ 10.6)

3.3 (0.8 ~ 7.8)

0.834

Male gender

25 (58.1%)

13 (54.2%)

0.801

Duration of admission (days)

6.0 (3.0 ~ 27.0)

8.0 (4.0 ~ 36.0)

0.059

Abdominal pain/vomiting

24 (55.8%)

13 (54.2%)

1.000

Duration of fever (days)

5.0 (3.0 ~ 9.0)

5.0 (3.0 ~ 19.0)

0.547

Typical Kawasaki disease

23 (53.5%)

16 (66.7%)

0.317

Fever ≥ 5 days

38 (88.4%)

23 (95.8%)

0.408

Dysmorphous skin rash

36 (83.7%)

22 (91.7%)

0.472

Oral mucosal change

33 (76.7%)

19 (79.2%)

0.820

Conjunctivitis

39 (90.7%)

17 (70.8%)

0.046*

Cervical lymphadenopathy

28 (65.1%)

19 (79.2%)

0.228

Peripheral extremity change

17 (39.5%)

17 (70.8%)

0.021*

Duration till recovery of LFT (days)

6.0 (1.0 ~ 43.0)

6.0 (3.0 ~ 100.0)

0.333

Frequency of IVIG infusion

1.0 (0 ~ 2.0)

1.0 (0 ~ 3.0)

0.261

  1. Data are presented as median (range) or numbers (%).
  2. *p < 0.05.
  3. †AAC group: the sum of definite AAC and suspected AAC.
  4. AAC, acute acalculous cholecystitis; IVIG, intravenous immunoglobulin; LFT, liver function test.